Drug News & Perspectives
Overview
    Drug News & Perspectives is a scientific journal, published by Thomson Reuters since 1988 in English. The journal's country of origin is United States and its primary focus area is pharmacology.
  
  Details
        Details
            Abbr.
            Drug News Perspect
          
                      
              Publisher
              Thomson Reuters
            
          
                      
              Start
              1988
            
          
                      
              End
              2010
            
          
                      
              Frequency
              Ten no. a year
            
          
                      
              p-ISSN
              0214-0934
            
          
                      
              e-ISSN
              2013-0139
            
          
                      
              Country
              United States
            
          
                      
              
                Language
              
              
                                  English
                  
                              
            
          
                      
              
                Specialty
              
              
                                  Pharmacology
                  
                              
            
          
                      
  
  Recent Articles
          1.
        
    
    Maggon K
  
  
    Drug News Perspect
    . 2013 Apr;
          16 Suppl:1-19.
    
    PMID: 23573553
  
  
          This is the story of my quest to jump-start new drug development activities in India at the custom synthesis, animal models, bulk drug production, toxicology and preclinical stages. A snapshot...
      
2.
        
    
    Debnath B, Al-Mawsawi L, Neamati N
  
  
    Drug News Perspect
    . 2010 Dec;
          23(10):670-84.
    
    PMID: 21180653
  
  
          For the last two decades, we have seen remarkable growth in the pharmaceutical industry. This growth has mainly been due to the approximately 100 new blockbuster drugs, such as Lipitor®...
      
3.
        
                      4.
        
    
    Wei J, Xie L, Taron M, Rosell R, Liu B
  
  
    Drug News Perspect
    . 2010 Dec;
          23(10):655-61.
    
    PMID: 21180651
  
  
          MicroRNAs (miRNAs) are a class of short noncoding RNAs that participate in mastering the balance of gene-regulating networks. By targeting and controlling expression of messenger RNA, miRNAs can control highly...
      
5.
        
    
    Frelin L, Brass A, Ahlen G, Brenndorfer E, Chen M, Sallberg M
  
  
    Drug News Perspect
    . 2010 Dec;
          23(10):647-53.
    
    PMID: 21180650
  
  
          The without a doubt major obstacle for making DNA vaccines a commercial success is delivery. If delivery cannot be made simple, cheap and effective, DNA vaccines may not become a...
      
6.
        
    
    Chauhan S, Sharma M, Chauhan P
  
  
    Drug News Perspect
    . 2010 Dec;
          23(10):632-46.
    
    PMID: 21180649
  
  
          Artemisinin, with its 1,2,4-trioxane as active motif, is now the first-line treatment for multidrug-resistant malaria. The endoperoxide ring is essential for the antimalarial activity of artemisinin. Based on its mechanism...
      
7.
        
    
    Biderman B, Marakhonov A, Skoblov M, Birerdinc A, Nohelty E, Page S, et al.
  
  
    Drug News Perspect
    . 2010 Dec;
          23(10):625-31.
    
    PMID: 21180648
  
  
          Chronic lymphocytic leukemia (CLL) represents 22-30% of all leukemia cases, thus being the most commonly diagnosed form of adult leukemia in the Western world. On a cellular level, the disease...
      
8.
        
    
    Kalscheuer R, Jacobs Jr W
  
  
    Drug News Perspect
    . 2010 Dec;
          23(10):619-24.
    
    PMID: 21180647
  
  
          Largely neglected by the industrialized world for decades, tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis, has made a fulminant return to the public health agenda as a major global...
      
9.
        
    
    Wang A, Montori V, Murad M
  
  
    Drug News Perspect
    . 2010 Dec;
          23(9):607-12.
    
    PMID: 21152455
  
  
          Fifty years ago, the issue of conflict of interest in biomedical research appeared in the national spotlight and has remained in a state of constant evolution. Government legislation caused a...
      
10.